CBL and lung cancer: Our model also captured the behaviour of an EGFR mutant (L834R) that occurs in lung cancer (reviewed in ref. 43) and displays increased phosphorylation together with decreased binding to Cbl and ubiquitination11, 44, 45, 46, 47.